How to Buy Si Bone Stock
Si Bone Inc
SI-BONE, Inc. , a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.
Si Bone stock last closed at $24.27, down 1.1% from the previous day, and has increased 71.16% in one year. It has overperformed other stocks in the Medical Devices industry by 0.73 percentage points. Si Bone stock is currently +117.86% from its 52-week low of $11.14, and -10.9% from its 52-week high of $27.24.
As of May 26, 2023, there are 35.18M SIBN shares outstanding. The market cap of SIBN is $853.92M. In the past 24 hours, 202,194 SIBN shares were traded.
How to Buy Si Bone Stock
Wondering how to invest in Si Bone stock? Here's how.
- Decide where to buy Si Bone stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you figure out where to buy Si Bone stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit money your brokerage account: Select your method of payment and add your information.
- Analyze Si Bone stock: The Si Bone ticker symbol is SIBN. Is Si Bone stock a good investment? Should you buy shares of SIBN? How do SIBN's underlying business fundamentals look? Do top analysts think Si Bone is a good buy? Why has SIBN's stock price moved recently? (Hint: Our stock research website can help you evaluate if SIBN is a good stock to buy).
- Execute your SIBN trade: Decide if you will purchase SIBN shares at the current market price or use a limit order to purchase SIBN stock at a given price.
- Keep tabs on your investment in SIBN: Create a watchlist to keep tabs on your position in Si Bone shares.
Step 1: Decide where to buy Si Bone stock
You need a brokerage account in order to access the NASDAQ market and buy SIBN stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global financial markets: From Tech to Financial Services, New York to Hong Kong — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro now.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal information so you can buy SIBN today.
How to Open a New Investment Account on eToro
- Click here to get started.
- Input your personal info to start a new trading account.
- Send your info by pressing the "Create Account" button.
Step 3: Deposit money your brokerage account
Now that you have opened your account on app for investing, you can securely and quickly fund your account:
Check out this video walkthrough to see the process of transferring funds into your investment account.
Step 4: Analyze Si Bone stock
After you have decided on the best place to buy Si Bone stock, it's crucial to evaluate their stock prior to investing, so you truly wrap your head around the risk as well as the upside.
Si Bone Numbers
Si Bone Zen Score
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on SIBN's stock page.
What is the fair value of SIBN stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge SIBN's fair value.
Using relative valuations ratios:
- SIBN could be overvalued based on its P/B ratio of 9.09x, relative to Medical Devices industry P/B ratio of 3.87x
You can do additional valuation research on SIBN's stock here.
Is SIBN a healthy company?
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the SIBN balance sheet.
- SIBN has cash burn of 48708000. It has sufficient cash and short-term investments to cover this for at least one year.
- SIBN has $85.97M in cash and short term investments. This is enough to cover its annual cash burn of $48.71M.
- There are more short-term assets than short-term liabilities on the SIBN balance sheet.
Negative Financial Indicators:
- SIBN profit margin has gone up by 0.2 percentage points in the past year, but the company is still unprofitable.
- SIBN has a relatively high debt to equity ratio of 0.59.
Is Si Bone stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 7 Wall Street analysts who give recommendations on SIBN, the consensus analyst rating on SIBN is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent SIBN Analyst Forecasts
Ross Osborn, a bottom 20% analyst from Cantor Fitzgerald maintains SIBN with a strong buy rating and raises their SIBN price target from $24.00 to $30.00, on May 2, 2023.
Drew Ranieri, a top 23% analyst from Morgan Stanley maintains SIBN with a strong buy rating and raises their SIBN price target from $22.00 to $27.00, on May 2, 2023.
David Turkaly, a bottom 8% analyst from JMP Securities reiterates SIBN with a buy rating and maintains their SIBN price target from $32.00 to $32.00, on May 2, 2023.
Kyle Rose, a top 4% analyst from Canaccord Genuity maintains SIBN with a strong buy rating and raises their SIBN price target from $24.00 to $27.00, on May 2, 2023.
Maintaining his Strong Buy rating, Rose raised his price target on SI-Bone Inc. by 12.5% following the release of the company's Q1 2023 earnings report on 2023/05/01.
Investors should "take a hard look" at SI-Bone ahead of "a potentially prolonged period of execution in 2023," the analyst recommended, arguing that investments in commercial infrastructure and reimbursement tailwinds "will translate to productivity gains and upside to estimates for SI-Bone through 2023 and beyond."
For Q1 2023, SI-Bone reported:
- Loss per share of $0.32, which beat the Zacks Consensus Estimate of $(0.41) and, by 38.5%, Q1 2022's $(0.52).
- Revenue of $32.71M, which beat the Zacks Consensus Estimate of $29.2M and, by 45.8%, Q1 2022's $22.44M.
- Gross margin of 82%.
Management updated its FY 2023 guide:
- Revenue of $128M to $131M.
- Gross margin of 80%.
CEO Laura Francis commented, “I am thrilled with our stellar start to 2023, as record procedure demand in the quarter allowed us to deliver approximately 50% U.S. revenue growth and achieve significant operating leverage.
“The continued trend of accelerating revenue growth over the last several quarters is a testament to the strong reception for our expanded portfolio of solutions.
"With yet another quarter of record increase in our active surgeon base combined with the favorable reimbursement framework, we are at an inflection in the business.
"These trends solidify my conviction in our ability to deliver strong and sustainable growth and drive operating leverage as we progress through the year."
David Saxon, a bottom 23% analyst from Needham maintains SIBN with a buy rating and raises their SIBN price target from $24.00 to $27.00, on May 2, 2023.
You can dig deeper into what analysts are projecting on the Si Bone stock forecast page.
SIBN Trading Indicators
How is SIBN performing as a company?
Last year, SIBN revenue was $116.68M. In the past four year, SIBN's revenue has grown by 19.27% per year. This was faster than the Medical Devices industry average of 12.46%.
Dive into SIBN's earnings and revenue performance here.
Who is buying/selling SIBN?
Over the last year, executives and large shareholders at SIBN have sold more shares than they have bought.
Anthony J. Recupero, President Commercial Ops of SIBN, was the latest SIBN insider to sell. They sold $74,643.28 worth of SIBN shares on May 17, 2023.
Get more info about who owns SIBN shares here.
Does SIBN stock generate passive income?
No, Si Bone doesn't provide an income stream by paying out dividends.
What do other investors have to say about SIBN?
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your SIBN trade
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular price limit, place a limit order.
Press the Open button and eToro will execute the order.
If you require more help with investing in stocks on eToro, click the helpful video below:
Step 6: Keep tabs on your investment in SIBN
Now that you own some SIBN shares, you'll want to keep up with your new shares.
Create a watchlist to get notified of important updates regarding your SIBN stock.
SIBN Feed
How to Buy Stock in Si Bone
To summarize, here are the 6 steps to buy stock in Si Bone:
- Decide where to buy Si Bone stock
- Create your brokerage account
- Deposit money your brokerage account
- Analyze Si Bone stock
- Execute your SIBN trade
- Keep tabs on your investment in SIBN
If you need a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Si Bone, add SIBN to your watchlist below.
More Content You Might Like
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.